ERT eCOA

We built more than 40 years of scientific and technical experience into our eCOA environment. In fact, we’ve completed 2100+ eCOA trials, overseen 50+ eCOA drug approvals, managed 120K eCOA sites, and enrolled 838K eCOA patients to date. With streamlined workflows and regulatory adherence, ERT eCOA is effective because it’s easy to use and reduces burden for both sites and patients. Accelerate your research with eCOA technology that doesn’t get in the way.

New Product Announcement

• ERT Reduces eCOA Delivery Time For Vaccine Trials By 75%

Articles

• eCOA Increases Patient-Site Communication and Candor
• Using Mobile Technology to Support Patients and Complex Protocols in Clinical Studies
• What are You Wearing? Scientific and Operational Considerations of Wearable Devices in Clinical Trials
• Improving Patient Engagement Through eCOA
• Just Say No to Paper Back-Ups
• Moving from Paper to Mobile: Validation of Mobile Electronic PRO/COA
• 21st Century Trials Demand 21st Century Technology
• Collecting eCOA in Dermatology Trials
• Using eCOA for the First Time
• The Impact Of Rater Training On Clinical Outcomes Assessment Data

White Paper

• Patients Prefer eCOA Over Paper COA
• Optimizing Rare Disease Outcomes Through eCOA Technology And Training

Case Study

• Electronic Columbia Suicide Severity Rating Scale Included In A Wider Range Of Clinical Studies
• Celgene Leverages ERT eCOA Data for FDA Approval
• eCOA Supports Successful Antianginal Trial

Science Briefs

• 2017 Global Regulatory And ISPOR Guidance Update

Infographics

• Minimize Risk And Uncertainty In Oncology Clinical Trials

Videos

• Overcoming the Limitations of Paper Diaries In Clinical Trials
• Leveraging eCOA Advancements
• Preparing for Clinical Trial Success

For more information, go to ert.com or email sales@ert.com